Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis

Background: Pulmonary fibrosis (PF) is a lung disease with no curative drug, characterized by a progressive decrease in lung function. Metformin (MET) is a hypoglycemic agent with the advantages of high safety and low cost and has been used in several in vivo trials to treat fibrotic diseases. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xuanyu, Xiao, Xiang, Chen, Xinyu, Yang, Maoyi, Hu, Zhipeng, Shuai, Sijia, Fu, Qinwei, Yang, Han, Du, Quanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485720/
https://www.ncbi.nlm.nih.gov/pubmed/36147352
http://dx.doi.org/10.3389/fphar.2022.948101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485720/
https://www.ncbi.nlm.nih.gov/pubmed/36147352
http://dx.doi.org/10.3389/fphar.2022.948101

Ejemplares similares